ABSTRACT
Fertility preservation for females is a medical issue of the utmost importance that has recently gained attention by researchers, health-care providers, and the public. Fertility preservation should be considered in cases of patients with malignant diseases undergoing potentially gonadotoxic treatments, patients with other diseases undergoing similar treatments, such as some cases of systemic lupus erythematosus (SLE), and practically by all women at risk for premature ovarian failure. Fertility preservation may also be considered for women approaching their fourth decade without a partner to start a family but wishing to preserve their fertility potential.
